Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Prime hAd5 Spike + Nucleocapsid Vaccination Induces Ten-Fold Increases in Mean T-Cell Responses in Phase 1 Subjects that are Sustained Against Spike Variants

Peter Sieling, Thomas King, Raymond Wong, Andy Nguyen, Kamil Wnuk, Elizabeth Gabitzsch, Adrian Rice, Helty Adisetiyo, Melanie Hermreck, Mohit Verma, Lise Zakin, Annie Shin, Brett Morimoto, Wendy Higashide, Kyle Dinkins, Joseph Balint, Victor Peykov, Justin Taft, View ORCID ProfileRoosheel Patel, Sofija Buta, Marta Martin-Fernandez, Dusan Bogunovic, Patricia Spilman, Lennie Sender, Sandeep Reddy, Philip Robinson, Shahrooz Rabizadeh, Kayvan Niazi, View ORCID ProfilePatrick Soon-Shiong
doi: https://doi.org/10.1101/2021.04.05.21254940
Peter Sieling
1ImmunityBio, LLC, 9920 Jefferson Blvd., Culver City, CA 90232, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Thomas King
1ImmunityBio, LLC, 9920 Jefferson Blvd., Culver City, CA 90232, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Raymond Wong
1ImmunityBio, LLC, 9920 Jefferson Blvd., Culver City, CA 90232, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Andy Nguyen
1ImmunityBio, LLC, 9920 Jefferson Blvd., Culver City, CA 90232, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kamil Wnuk
1ImmunityBio, LLC, 9920 Jefferson Blvd., Culver City, CA 90232, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Elizabeth Gabitzsch
1ImmunityBio, LLC, 9920 Jefferson Blvd., Culver City, CA 90232, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Adrian Rice
1ImmunityBio, LLC, 9920 Jefferson Blvd., Culver City, CA 90232, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Helty Adisetiyo
1ImmunityBio, LLC, 9920 Jefferson Blvd., Culver City, CA 90232, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Melanie Hermreck
1ImmunityBio, LLC, 9920 Jefferson Blvd., Culver City, CA 90232, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mohit Verma
1ImmunityBio, LLC, 9920 Jefferson Blvd., Culver City, CA 90232, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lise Zakin
1ImmunityBio, LLC, 9920 Jefferson Blvd., Culver City, CA 90232, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Annie Shin
1ImmunityBio, LLC, 9920 Jefferson Blvd., Culver City, CA 90232, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Brett Morimoto
1ImmunityBio, LLC, 9920 Jefferson Blvd., Culver City, CA 90232, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Wendy Higashide
1ImmunityBio, LLC, 9920 Jefferson Blvd., Culver City, CA 90232, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kyle Dinkins
1ImmunityBio, LLC, 9920 Jefferson Blvd., Culver City, CA 90232, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Joseph Balint
1ImmunityBio, LLC, 9920 Jefferson Blvd., Culver City, CA 90232, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Victor Peykov
1ImmunityBio, LLC, 9920 Jefferson Blvd., Culver City, CA 90232, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Justin Taft
2Center for Inborn Errors of Immunity, Icahn School of Medicine at Mount Sinai, 1 Gustave Lane, Levy Place, New York, NY 10029-5674, USA SPA
5Mindich Child Health and Development Institute, Icahn School of Medicine at Mount Sinai, 1 Gustave Lane, Levy Place, New York, NY 10029-5674, USA SPA
6Department of Microbiology, Icahn School of Medicine at Mount Sinai, 1 Gustave Lane, Levy Place, New York, NY 10029-5674, USA SPA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Roosheel Patel
2Center for Inborn Errors of Immunity, Icahn School of Medicine at Mount Sinai, 1 Gustave Lane, Levy Place, New York, NY 10029-5674, USA SPA
3Department of Pediatrics, Icahn School of Medicine at Mount Sinai, 1 Gustave Lane, Levy Place, New York, NY 10029-5674, USA SPA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Roosheel Patel
Sofija Buta
2Center for Inborn Errors of Immunity, Icahn School of Medicine at Mount Sinai, 1 Gustave Lane, Levy Place, New York, NY 10029-5674, USA SPA
3Department of Pediatrics, Icahn School of Medicine at Mount Sinai, 1 Gustave Lane, Levy Place, New York, NY 10029-5674, USA SPA
4Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, 1 Gustave Lane, Levy Place, New York, NY 10029-5674, USA SPA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marta Martin-Fernandez
2Center for Inborn Errors of Immunity, Icahn School of Medicine at Mount Sinai, 1 Gustave Lane, Levy Place, New York, NY 10029-5674, USA SPA
3Department of Pediatrics, Icahn School of Medicine at Mount Sinai, 1 Gustave Lane, Levy Place, New York, NY 10029-5674, USA SPA
4Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, 1 Gustave Lane, Levy Place, New York, NY 10029-5674, USA SPA
5Mindich Child Health and Development Institute, Icahn School of Medicine at Mount Sinai, 1 Gustave Lane, Levy Place, New York, NY 10029-5674, USA SPA
6Department of Microbiology, Icahn School of Medicine at Mount Sinai, 1 Gustave Lane, Levy Place, New York, NY 10029-5674, USA SPA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Dusan Bogunovic
2Center for Inborn Errors of Immunity, Icahn School of Medicine at Mount Sinai, 1 Gustave Lane, Levy Place, New York, NY 10029-5674, USA SPA
3Department of Pediatrics, Icahn School of Medicine at Mount Sinai, 1 Gustave Lane, Levy Place, New York, NY 10029-5674, USA SPA
4Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, 1 Gustave Lane, Levy Place, New York, NY 10029-5674, USA SPA
5Mindich Child Health and Development Institute, Icahn School of Medicine at Mount Sinai, 1 Gustave Lane, Levy Place, New York, NY 10029-5674, USA SPA
6Department of Microbiology, Icahn School of Medicine at Mount Sinai, 1 Gustave Lane, Levy Place, New York, NY 10029-5674, USA SPA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Patricia Spilman
1ImmunityBio, LLC, 9920 Jefferson Blvd., Culver City, CA 90232, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lennie Sender
7NantKwest, Inc., 9920 Jefferson Blvd., Culver City, CA 90232, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sandeep Reddy
7NantKwest, Inc., 9920 Jefferson Blvd., Culver City, CA 90232, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Philip Robinson
8Hoag Hospital, Newport Beach, CA 92663, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Shahrooz Rabizadeh
1ImmunityBio, LLC, 9920 Jefferson Blvd., Culver City, CA 90232, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kayvan Niazi
1ImmunityBio, LLC, 9920 Jefferson Blvd., Culver City, CA 90232, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Patrick Soon-Shiong
1ImmunityBio, LLC, 9920 Jefferson Blvd., Culver City, CA 90232, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Patrick Soon-Shiong
  • For correspondence: Patrick@Nantworks.com
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

ABSTRACT

In response to the need for a safe, efficacious vaccine that elicits vigorous T cell as well as humoral protection against SARS-CoV-2 infection, we have developed a dual-antigen COVID-19 vaccine comprising both the viral spike (S) protein modified to increase cell-surface expression (S-Fusion) and nucleocapsid (N) protein with an Enhanced T-cell Stimulation Domain (N-ETSD) to enhance MHC class I and II presentation and T-cell responses. The antigens are delivered using a human adenovirus serotype 5 (hAd5) platform with E1, E2b, and E3 regions deleted that has been shown previously in cancer vaccine studies to be safe and effective in the presence of pre-existing hAd5 immunity. The findings reported here are focused on human T-cell responses due to the likelihood that such responses will sustain efficacy against emerging variants, a hypothesis supported by our in silico prediction of T-cell epitope HLA binding for both the first-wave SARS-CoV-2 ‘A’ strain and the B.1.351 strain K417N, E484K, and N501Y spike and T201I N variants. We demonstrate the hAd5 S-Fusion + N-ETSD vaccine antigens expressed by previously SARS-CoV-2-infected patient dendritic cells elicit Th1 dominant activation of autologous patient T cells, indicating the vaccine antigens have the potential to elicit immune responses in previously infected patients. For participants in our open-label Phase 1b study of the vaccine (NCT04591717; https://clinicaltrials.gov/ct2/show/NCT04591717), the magnitude of Th-1 dominant S- and N-specific T-cell responses after a single prime subcutaneous injection were comparable to T-cell responses from previously infected patients. Furthermore, vaccinated participant T-cell responses to S were similar for A strain S and a series of spike variant peptides, including S variants in the B.1.1.7 and B.1.351 strains. The findings that this dual-antigen vaccine elicits SARS-CoV-2-relevant T-cell responses and that such cell-mediated protection is likely to be sustained against emerging variants supports the testing of this vaccine as a universal booster that would enhance and broaden existing immune protection conferred by currently approved S-based vaccines.

Competing Interest Statement

All authors with an ImmunityBio, Inc. or NantKwest affiliation contributed to the conception, design, generation or testing of the vaccine described, which may become a commercial product

Clinical Trial

NCT04591717

Clinical Protocols

https://www.clinicaltrials.gov/ct2/show/NCT04591717?term=QUILT&cond=COVID-19&draw=2&rank=2

Funding Statement

Funded by ImmunityBio, Inc.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

The Western IRB for the Chan Soon-Shiong Institute for Medicine (CSSIFM) and the Hoag Hospital Providence IRB at Hoag Hospital Newport Beach

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Footnotes

  • Phase 1b clinical trial study participant T cells were tested for reactivity against mutated spike peptides from SARS-CoV-2 variants B.1.351, B.1.1.7, P.1 and B.1.429 and showed sustained reactivity, suggesting potential for vaccine efficacy against these variants.

Data Availability

All data are reported in the manuscript

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Back to top
PreviousNext
Posted June 09, 2021.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Prime hAd5 Spike + Nucleocapsid Vaccination Induces Ten-Fold Increases in Mean T-Cell Responses in Phase 1 Subjects that are Sustained Against Spike Variants
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Prime hAd5 Spike + Nucleocapsid Vaccination Induces Ten-Fold Increases in Mean T-Cell Responses in Phase 1 Subjects that are Sustained Against Spike Variants
Peter Sieling, Thomas King, Raymond Wong, Andy Nguyen, Kamil Wnuk, Elizabeth Gabitzsch, Adrian Rice, Helty Adisetiyo, Melanie Hermreck, Mohit Verma, Lise Zakin, Annie Shin, Brett Morimoto, Wendy Higashide, Kyle Dinkins, Joseph Balint, Victor Peykov, Justin Taft, Roosheel Patel, Sofija Buta, Marta Martin-Fernandez, Dusan Bogunovic, Patricia Spilman, Lennie Sender, Sandeep Reddy, Philip Robinson, Shahrooz Rabizadeh, Kayvan Niazi, Patrick Soon-Shiong
medRxiv 2021.04.05.21254940; doi: https://doi.org/10.1101/2021.04.05.21254940
Digg logo Reddit logo Twitter logo Facebook logo Google logo LinkedIn logo Mendeley logo
Citation Tools
Prime hAd5 Spike + Nucleocapsid Vaccination Induces Ten-Fold Increases in Mean T-Cell Responses in Phase 1 Subjects that are Sustained Against Spike Variants
Peter Sieling, Thomas King, Raymond Wong, Andy Nguyen, Kamil Wnuk, Elizabeth Gabitzsch, Adrian Rice, Helty Adisetiyo, Melanie Hermreck, Mohit Verma, Lise Zakin, Annie Shin, Brett Morimoto, Wendy Higashide, Kyle Dinkins, Joseph Balint, Victor Peykov, Justin Taft, Roosheel Patel, Sofija Buta, Marta Martin-Fernandez, Dusan Bogunovic, Patricia Spilman, Lennie Sender, Sandeep Reddy, Philip Robinson, Shahrooz Rabizadeh, Kayvan Niazi, Patrick Soon-Shiong
medRxiv 2021.04.05.21254940; doi: https://doi.org/10.1101/2021.04.05.21254940

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Allergy and Immunology
Subject Areas
All Articles
  • Addiction Medicine (179)
  • Allergy and Immunology (434)
  • Anesthesia (99)
  • Cardiovascular Medicine (949)
  • Dentistry and Oral Medicine (178)
  • Dermatology (111)
  • Emergency Medicine (260)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (422)
  • Epidemiology (8997)
  • Forensic Medicine (4)
  • Gastroenterology (421)
  • Genetic and Genomic Medicine (1960)
  • Geriatric Medicine (191)
  • Health Economics (403)
  • Health Informatics (1330)
  • Health Policy (661)
  • Health Systems and Quality Improvement (520)
  • Hematology (212)
  • HIV/AIDS (420)
  • Infectious Diseases (except HIV/AIDS) (10820)
  • Intensive Care and Critical Care Medicine (575)
  • Medical Education (200)
  • Medical Ethics (54)
  • Nephrology (222)
  • Neurology (1834)
  • Nursing (110)
  • Nutrition (274)
  • Obstetrics and Gynecology (356)
  • Occupational and Environmental Health (470)
  • Oncology (1000)
  • Ophthalmology (299)
  • Orthopedics (111)
  • Otolaryngology (183)
  • Pain Medicine (126)
  • Palliative Medicine (44)
  • Pathology (265)
  • Pediatrics (581)
  • Pharmacology and Therapeutics (276)
  • Primary Care Research (234)
  • Psychiatry and Clinical Psychology (1907)
  • Public and Global Health (4127)
  • Radiology and Imaging (676)
  • Rehabilitation Medicine and Physical Therapy (368)
  • Respiratory Medicine (550)
  • Rheumatology (226)
  • Sexual and Reproductive Health (191)
  • Sports Medicine (178)
  • Surgery (207)
  • Toxicology (39)
  • Transplantation (109)
  • Urology (82)